Ikena Oncology
Stock Forecast, Prediction & Price Target
Ikena Oncology Financial Estimates
Ikena Oncology Revenue Estimates
Ikena Oncology EBITDA Estimates
Ikena Oncology Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $30.98M N/A | $15.61M -49.59% | $9.16M -41.34% | Avg: $3.5M Low: $3.5M High: $3.5M avg. -61.79% | Avg: $3.5M Low: $3.5M High: $3.5M avg. 0% | Avg: $9.33M Low: $9.33M High: $9.33M avg. 166.66% | Avg: $70M Low: $70M High: $70M avg. 650.00% |
Net Income
% change YoY
| $-34.11M N/A | $-66.62M -95.29% | $-68.16M -2.31% | Avg: $-60.27M Low: $-61.35M High: $-25.45M avg. 11.57% | Avg: $-65.14M Low: $-56.75M High: $-21.28M avg. -8.07% | Avg: $-32.55M Low: $-32.55M High: $-32.55M avg. 50.03% | Avg: $-16.69M Low: $-16.69M High: $-16.69M avg. 48.71% |
EBITDA
% change YoY
| $-33.59M N/A | $-70.15M -108.82% | $-74.39M -6.04% | Avg: $-3.5M Low: $-3.5M High: $-3.5M avg. 95.29% | Avg: $-3.5M Low: $-3.5M High: $-3.5M avg. 0% | Avg: $-9.33M Low: $-9.33M High: $-9.33M avg. -166.66% | Avg: $-70M Low: $-70M High: $-70M avg. -650.00% |
EPS
% change YoY
| -$0.95 N/A | -$1.84 -93.68% | -$1.63 11.41% | Avg: -$1.05 Low: -$1.47 High: -$0.61 avg. 35.42% | Avg: -$0.99 Low: -$1.36 High: -$0.51 avg. 5.93% | Avg: -$0.78 Low: -$0.78 High: -$0.78 avg. 21.21% | Avg: -$0.4 Low: -$0.4 High: -$0.4 avg. 48.71% |
Operating Expenses
% change YoY
| $65.12M N/A | $86.52M 32.85% | $84.57M -2.24% | Avg: $4.35M Low: $4.35M High: $4.35M avg. -94.85% | Avg: $4.35M Low: $4.35M High: $4.35M avg. 0% | Avg: $11.60M Low: $11.60M High: $11.60M avg. 166.66% | Avg: $87.07M Low: $87.07M High: $87.07M avg. 650.00% |
FAQ
What is Ikena Oncology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 25.56% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -61.35M, average is -60.27M and high is -25.45M.
What is Ikena Oncology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 188.71% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $3.5M, average is $3.5M and high is $3.5M.
What is Ikena Oncology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 27.82% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.47, average is -$1.05 and high is $-0.61.
What is the best performing analyst?
In the last twelve months analysts have been covering Ikena Oncology stock. The most successful analyst is David Nierengarten.